author-photo

Peter Tyrer

MedImmune

10

Papers

164

Citations

Citation Trend

Filter By

Papers (7) Sort By

Journal Conference Others

ADCT-402, a PBD dimer-containing antibody drug conjugate targeting CD19-expressing malignancies

2018 Blood
Show All
- Source
- Cite
- Save
Citations (54)
Abstract 744: ADCT-701, a novel pyrrolobenzodiazepine (PBD) dimer-based antibody-drug conjugate (ADC) targeting DLK1-expressing tumors

2018 Cancer Research
Show All
- Source
- Cite
- Save
Citations (2)
Antitumor Activity of MEDI3726 (ADCT-401), a Pyrrolobenzodiazepine Antibody–Drug Conjugate Targeting PSMA, in Preclinical Models of Prostate Cancer

2018 Molecular Cancer Therapeutics
Show All
- Source
- Cite
- Save
Citations (20)
Abstract 52: Mechanistic and benchmarking studies of ADCT-502, a pyrrolobenzodiazepine (PBD) dimer-containing antibody-drug conjugate (ADC) targeting HER2-expressing solid tumors

2017 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)
Abstract 3111A: ADCT-401/MEDI3726, a novel pyrrolobenzodiazepine (PBD)-based antibody-drug conjugate (ADC) targeting PSMA-expressing prostate cancers

2017 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
ADCT-502, a novel pyrrolobenzodiazepine (PBD)-based antibody-drug conjugate (ADC) targeting low HER2-expressing solid cancers

2016 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (11)
hLL2-Cys-PBD, a New Site-Specifically Conjugated, Pyrrolobenzodiazepine (PBD) Dimer-Based Antibody Drug Conjugate (ADC) Targeting CD22-Expressing B-Cell Malignancies.

2016 Blood
Show All
- Source
- Cite
- Save
Citations (6)